Charidimou, Andreas
Harvard Medical School,
United States
2024 Rank: 19709
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
General & Internal Medicine
Rank in SubField 1: 972 out of 341636 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 19709 | 15940 |
| Total Cites | 1562 | 1942 |
| H-index | 20 | 23 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 102 | 102 |
| Total Cites to Single+First Authored Papers | 612 | 738 |
| Number of Single+First+Last Authored Papers | 113 | 113 |
| Total Cites to Single+First+Last Authored Papers | 712 | 850 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 821 | 945 |
| Ratio of Total Citations to Distinct Citing Papers | 1.90 | 2.06 |
| Self-Citation Percentage |
19.57%
|
|
Charidimou, Andreas
Boston University Chobanian & Avedisian School of Medicine,
United States
2023 Rank: 24719
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
General & Internal Medicine
Rank in SubField 1: 1308 out of 323273 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 24719 | 21027 |
| Total Cites | 1410 | 1734 |
| H-index | 18 | 22 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 101 | 101 |
| Total Cites to Single+First Authored Papers | 530 | 619 |
| Number of Single+First+Last Authored Papers | 110 | 110 |
| Total Cites to Single+First+Last Authored Papers | 627 | 732 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 815 | 944 |
| Ratio of Total Citations to Distinct Citing Papers | 1.73 | 1.84 |
| Self-Citation Percentage |
18.69%
|
|
Charidimou, Andreas
Massachusetts General Hospital,
United States
2022 Rank: 24278
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
General & Internal Medicine
Rank in SubField 1: 1408 out of 305851 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 24278 | 22099 |
| Total Cites | 1301 | 1580 |
| H-index | 18 | 20 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 98 | 98 |
| Total Cites to Single+First Authored Papers | 490 | 558 |
| Number of Single+First+Last Authored Papers | 107 | 107 |
| Total Cites to Single+First+Last Authored Papers | 572 | 653 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 728 | 841 |
| Ratio of Total Citations to Distinct Citing Papers | 1.79 | 1.88 |
| Self-Citation Percentage |
17.66%
|
|
Charidimou, Andreas
Harvard Medical School,
United States
2021 Rank: 29184
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
General & Internal Medicine
Rank in SubField 1: 1655 out of 278898 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 29184 | 24581 |
| Total Cites | 1706 | 2107 |
| H-index | 21 | 24 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 5 | 5 |
| Number of Single+First Authored Papers | 97 | 97 |
| Total Cites to Single+First Authored Papers | 690 | 816 |
| Number of Single+First+Last Authored Papers | 106 | 106 |
| Total Cites to Single+First+Last Authored Papers | 796 | 939 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 984 | 1132 |
| Ratio of Total Citations to Distinct Citing Papers | 1.73 | 1.86 |
| Self-Citation Percentage |
19.03%
|
|